Psychopharmacology and Psychiatry Updates

Un pódcast de Psychopharmacology Institute

Categorías:

252 Episodo

  1. Rethinking Antipsychotic Dosing: Lessons from the RADAR Trial

    Publicado: 6/1/2025
  2. Unraveling Agitation: Mania vs. Substance Use

    Publicado: 1/1/2025
  3. Pushing the Boundaries: Exploring High-Dose Antipsychotics

    Publicado: 27/12/2024
  4. The Psychodynamic Prescriber

    Publicado: 22/12/2024
  5. From Inpatient to Outpatient: Initiating Benzodiazepine Tapering

    Publicado: 17/12/2024
  6. The Power of Alliance in Psychopharmacology

    Publicado: 12/12/2024
  7. Antipsychotics in Youth: Balancing Metabolic Risk

    Publicado: 7/12/2024
  8. The Double-Edged Sword of Biological Explanations in Mental Health

    Publicado: 2/12/2024
  9. New Insights into Psychiatric and Cardiovascular Comorbidity

    Publicado: 27/11/2024
  10. Beyond the Pill: The Psychology of Psychopharmacology

    Publicado: 22/11/2024
  11. On Methylphenidate and Sleep: A Two-Year Study

    Publicado: 17/11/2024
  12. Nature's Pharmacy: Combining Natural Remedies in Psychiatry

    Publicado: 12/11/2024
  13. Breaking the Cycle: Memantine in Body-Focused Repetitive Behaviors

    Publicado: 7/11/2024
  14. The Potential of Ashwagandha in Psychiatry

    Publicado: 2/11/2024
  15. Treatment Dilemmas: ECT for Depressed Teens

    Publicado: 28/10/2024
  16. CBD in Psychiatry: Promise or Hype?

    Publicado: 23/10/2024
  17. Beyond Dopamine: Cannabidiol in Parkinson's Care

    Publicado: 18/10/2024
  18. Is NAC Promising in Bipolar and Depression Treatment?

    Publicado: 13/10/2024
  19. Microbes and the Mind: Probiotics and ADHD

    Publicado: 8/10/2024
  20. Lithium, Lamotrigine, and Labor: Managing Bipolar Disorder in Expectant Mothers

    Publicado: 3/10/2024

1 / 13

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

Visit the podcast's native language site